Hydrogen Research Study
← Back to Research Library
Review or synthesisNarrative reviewOther or not reported

Hydrogen treatment: a novel option in liver diseases.

Jian Shi, Brittany Duncan, Xuyuan Kuang · Clinical medicine (London, England) · 2021

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Liver and Fatty Liver Disease
Evidence type Review or synthesis
Publication type Narrative review
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

This narrative review examined the available evidence on molecular hydrogen. The reviewed evidence supports molecular hydrogen's therapeutic potential. Additional well-designed studies are needed to clarify clinical safety and effectiveness.

What the Review Examined

The review examined hydrogen treatment: a novel option in liver diseases.

Main Findings Across the Literature

Hydrogen therapy is a very promising treatment against several diseases due to its mild attributes, high affinity and inherent biosafety. However, there is little elaboration about current hydrogen treatment in liver diseases. The major focus is clinical hydrogen use and related mechanisms in liver dysfunction or diseases, including non-alcoholic fatty liver disease, hepatitis B, liver dysfunction caused by liver tumour and colorectal tumour chemotherapy.

H₂ Mechanisms / Biological Findings

The major focus is clinical hydrogen use and related mechanisms in liver dysfunction or diseases, including non-alcoholic fatty liver disease, hepatitis B, liver dysfunction caused by liver tumour and colorectal tumour chemotherapy.

Authors’ Conclusion

A distinct authors’ conclusion was not available in the source material reviewed by H2HUBB.